Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II (PCI2)
Sponsor: VA Office of Research and Development
This NA trial investigates Lung Cancer and is currently completed. VA Office of Research and Development leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
-
Nov 2021 — Aug 2023 [monthly]
Completed NA
-
Jan 2021 — Nov 2021 [monthly]
Completed NA
▶ Show 8 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Mar 2019 — Aug 2019 [monthly]
Recruiting NA
-
Oct 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Oct 2018 [monthly]
Recruiting NA
-
Nov 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jul 2017 — Nov 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .